Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 3/20 | 0.67 |
| ▸ | MME | P08473 | 1/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.64 |
| ▸ | CA2 | P00918 | 3/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.62 |
| ▸ | ACE | P12821 | 5/20 | 0.61 |
| ▸ | CTSS | P25774 | 1/20 | 0.59 |
| ▸ | CTSK | P43235 | 1/20 | 0.59 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.58 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.57 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4360734 | 1.00 | CTSL (0.67) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL28760302 | 1.00 | CTSL (0.67) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL11582248 | 1.00 | CTSL (0.67) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL4369236 | 1.00 | CTSL (0.67) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL11583747 | 0.99 | CTSL (0.66) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL4359080 | 0.99 | CTSL (0.66) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL11583740 | 0.99 | CTSL (0.66) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL4364597 | 0.95 | PTPN1 (0.64) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL4357736 | 0.93 | ACE (0.68) | CTSLMMEPTPN1CA2CA1 | |
| SCHEMBL4356229 | 0.93 | ACE (0.68) | CTSLMMEPTPN1CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9023809-B2 | Phenylalanine dipeptide derivatives, compositions and use thereof | THE KEY LABORATORY OF CHEMISTRY FOR NATURAL PRODUCTS OF GUIZHOU PROVINCE AND CHINESE ACADEMY OF SCIENCES (CN) | 2015-05-05 | — | — | US | disclosed |
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | The Key Lab. Of Chemistry for Natural Products of Guizhou Province and Chinese Acad. of Sciences (CN) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247470-A1 | PHENYLALANINE DIPEPTIDE DERIVATIVES, COMPOSITIONS AND USE THEREOF | DNPEP, PEPD, VIP | CTSL 591/4885MME 8/4885PTPN1 1817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.